LOOK WHO’S SELLING NTMD
The company’s chief medical officer exercised options to buy 60,000 shares last week at $1.16 and sold them for $21.94. In December, he sold 30,000 shares at $20.63 that he had acquired by exercising options at 8 cents a share. Meanwhile, the company itself has filed a ‘shelf registration’ to sell up to a quarter billion dollars worth of its stock and/or bonds – not an insignificant sum for a company this size.
Neither of these pieces of information is ‘dispositive,’ as they say – ‘finally determinative.’ But taken with the IMS prescription data suggesting that only a few hundred prescriptions for BiDil may have been written thus far (while expenses of more than $100 million for the year have been budgeted), one imagines that the chief medical officer, and the company, may be on to a good thing.
(A shelf registration doesn’t require a company to issue new securities, but puts it in a position to do so without regulatory delay.)
The stock closed last night at $19.90, for an overall market valuation, with just over 30 million shares outstanding, of $600 million.
Anything’s possible, but . . . don’t sell your puts.
BEFORE WE ATTACK IRAN . . .
The author argues that it’s a serious situation, but hardly a crisis.
Quote of the Day
To think that distasters only happen to someone else is human nature. But, when human nature runs into mother nature, regret normally follows.~CBS hurricane specialist Bryan Norcross
Request email delivery
- Feb 22:
Corruption On A Scale Never Previously Imagined
- Feb 21:
What A Field!
- Feb 20:
And Yet You Still Don’t Turn The Lights Off When You Leave The Room
- Feb 19:
Power Walking With Chris Christie
- Feb 18:
The Inspiration YOU Need?
- Feb 15:
NYC. UK. Canada.
- Feb 14:
If Republican Officials Go To Prison . . .
- Feb 13:
The National Butterfly Center Is Taking A Stand
- Feb 12:
Home-Schooled For Christ. And Pence.
- Feb 11:
Russian TV Thanks The GOP (And Don’t Miss Bill Maher)
- Feb 22: